🔎 Trials Near Me

Akèy › Ensifizyans kadyak › Texas › Dallas

Etid klinik pou Ensifizyans kadyak nan Dallas, TX

42 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

ELEVATE-HFpEF Clinical Study

Ap rekrite
  • Dallas VA Medical Center, Dallas
Laj 40 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Ap rekriteFaz 3
  • Research Site, Dallas
  • Research Site, Dallas
  • Research Site, Dallas
Laj 18 a 130 · Tout sèks · Mizajou Oct 2, 2026 · NCT06307652

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Ap rekriteFaz 3
  • Texas Health Research and Education Institute, Dallas
  • Southwest Family Medicine Associates, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06935370

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Ap rekriteFaz 3
  • Texas Health Research and Education Institute, Dallas
  • Southwest Family Medicine Associates, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06424288

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Ap rekrite
  • University of Texas Southwestern Medical Center, Dallas
  • Parkland Health & Hospital System (PHHS), Dallas
  • Baylor Scott and White - Health System, Dallas
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT06593327

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Ap rekriteFaz 3
  • Research Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Ap rekriteFaz 3
  • Baylor University Medical Center, Dallas
  • The University of Texas Southwestern Medical Center, Dallas
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06736574

Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

Ap rekrite
  • University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07222813

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Cedar Health Research, LLC, Dallas
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Ap rekriteFaz 3
  • Research Site, Dallas
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Ap rekriteFaz 3
  • Dallas, TX Investigative Site 10042, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Ap rekrite
  • Baylor University Medical Center, part of Baylor Scott & White Health, Dallas
  • UT southwestern Medical Center, Dallas
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

Ap rekriteFaz 2
  • Local Institution - 167, Dallas
Laj 30 a 84 · Tout sèks · Mizajou Aug 31, 2026 · NCT07795814

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Ap rekriteFaz 2/3
  • Children's Health-The Heart Center ( Site 0015), Dallas
29 Days – 17 Years · Tout sèks · Mizajou Aug 28, 2026 · NCT05714085

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Ap rekriteFaz 2
  • University of Texas Southwestern Medical Center, Dallas, Dallas
Laj 40 a 85 · Tout sèks · Mizajou Aug 27, 2026 · NCT06793371

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Ap rekriteEtid obsèvasyon
  • Dallas, Dallas
Tout laj · Tout sèks · Mizajou Aug 20, 2026 · NCT00271180

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Ap rekriteEtid obsèvasyon
  • North Texas Cardiology Center, Dallas
  • Baylor Scott & White Research Institute, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Ap rekriteFaz 3
  • Tenax Investigational Site, Dallas
Laj 18 a 85 · Tout sèks · Mizajou Aug 19, 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Renal Disease Research Institute, Dallas
  • Texas Health Heart and Vascular Specialists, Dallas
  • Southwest Family Medicine_Dallas, Dallas
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Alleviant ALLAY-HF Study

Ap rekrite
  • UT Southwestern, Dallas
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

Ap rekrite
  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Laj 60 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05996328

OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

Ap rekriteEtid obsèvasyon
  • Baylor University Medical Center, Dallas
Laj 18 a 99 · Tout sèks · Mizajou Aug 11, 2026 · NCT06939751

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Ap rekriteFaz 2
  • Children's Health Dallas, Dallas
Laj 0 a 16 · Tout sèks · Mizajou Aug 10, 2026 · NCT06080074

Assessment of CCM in HF With Higher Ejection Fraction

Ap rekrite
  • Baylor Scott and White Research Institute, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05064709

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Ap rekrite
  • Medical City Healthcare Dallas, Dallas
  • Baylor Scott & White -Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Ap rekrite
  • Baylor University Hospital, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

Home-based Cardiac Rehabilitation in Heart Failure

Ap rekriteFaz 3
  • University of Texas Southwestern Medical Center, Dallas
  • Baylor Scott and White Health System, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jun 2, 2026 · NCT06349941

IEEM-Heat and Heart Failure

Ap rekriteVolontè an sante akeyi
  • Institute for Exercise and Environmental Medicine - Texas Health Presbyterian Hospital Dallas, Dallas
Laj 45 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06961929

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

Ap rekrite
  • UT Southwestern Medical Center, Dallas
Tout laj · Tout sèks · Mizajou May 7, 2026 · NCT06593314

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Ap rekriteFaz 3
  • University of Texas Southwestern, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06217302

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

Ap rekrite
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT06895070

Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

Ap rekriteFaz 2
  • UT Southwestern Medical Center, Dallas
Laj 50 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT06130059

Cardiopulmonary Stress Testing (CPET) AlloSure Study

Ap rekriteEtid obsèvasyon
  • Baylor Scott & White health research institute, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT04656080

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients

Ap rekriteFaz 2
  • Baylor University Medical Center, Dallas
Laj 18 a 90 · Tout sèks · Mizajou Jan 22, 2026 · NCT03383419

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

Ap rekriteFaz 2/3
  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT04982419

Cardiogenic Shock Working Group Registry

Ap rekriteEtid obsèvasyon
  • Baylor Scott & White Advanced Heart Failure Clinic, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jun 6, 2025 · NCT04682483

Get With The Guidelines-Heart Failure Registry

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Amy Bennett, Dallas
Laj 18 a 125 · Tout sèks · Mizajou Jan 29, 2025 · NCT02693509

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Ap rekriteEtid obsèvasyon
  • UT Southwestern Medical Center, Dallas
Laj 20 a 90 · Tout sèks · Mizajou Aug 22, 2024 · NCT01258231

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Ap rekriteFaz 1/2
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 a 80 · Tout sèks · Mizajou Mar 26, 2024 · NCT04703842

Etid Ensifizyans kadyak nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.